Cohance Lifesciences Financials
NSE: COHANCE | BSE: 543064
₹438.00
₹-1.95
(-0.44%)
As on 18-Sep-2026IST
Market cap
₹16,760 Cr
Revenue (TTM)
₹2,142 Cr
P/E Ratio
157.8
P/B Ratio
4.4
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,141.50
|
2,268.55
|
2,608.50
|
1,051.35
|
1,340.33
|
1,320.22
|
|
|
|
|
|
|
Total Income
|
2,173.67
|
2,302.64
|
2,677.71
|
1,113.26
|
1,386.69
|
1,412.60
|
|
|
|
|
|
|
Total Expenditure
|
1,825.36
|
1,841.56
|
1,811.44
|
645.54
|
766.17
|
738.50
|
|
|
|
|
|
|
EBITDA
|
316.14
|
426.99
|
797.06
|
405.81
|
574.16
|
581.72
|
|
|
|
|
|
|
Depreciation
|
191.73
|
187.33
|
166.80
|
54.60
|
47.99
|
39.10
|
|
|
|
|
|
|
EBIT
|
124.41
|
239.66
|
630.26
|
351.21
|
526.18
|
542.62
|
|
|
|
|
|
|
Interest
|
33.80
|
37.24
|
41.06
|
7.45
|
12.81
|
8.53
|
|
|
|
|
|
|
Other Income
|
32.17
|
34.09
|
69.21
|
61.91
|
46.36
|
92.38
|
|
|
|
|
|
|
Exceptional Items
|
-21.37
|
-29.47
|
-15.78
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
101.41
|
207.04
|
642.63
|
405.67
|
559.73
|
667.59
|
|
|
|
|
|
|
Provision for Tax
|
42.88
|
56.92
|
158.39
|
105.39
|
148.44
|
213.78
|
|
|
|
|
|
|
Profit after Tax
|
58.53
|
150.12
|
484.24
|
300.28
|
411.29
|
453.80
|
|
|
|
|
|
|
Minority Interest
|
47.70
|
29.11
|
3.10
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
106.23
|
179.23
|
487.34
|
300.28
|
411.29
|
453.80
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,911.29
|
3,911.29
|
3,648.82
|
2,050.67
|
1,735.18
|
1,527.18
|
|
|
|
|
|
|
Minority Interest
|
47.70
|
122.54
|
144.06
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
1,049.88
|
1,047.24
|
982.12
|
86.03
|
71.79
|
92.11
|
|
|
|
|
|
|
Current Liabilities
|
645.93
|
645.93
|
705.41
|
117.40
|
303.09
|
347.52
|
|
|
|
|
|
|
Total Liabilities
|
5,729.64
|
5,727.00
|
5,480.41
|
2,254.10
|
2,110.07
|
1,966.81
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
3,581.55
|
3,899.04
|
3,686.93
|
1,000.89
|
954.70
|
701.66
|
|
|
|
|
|
|
Current Assets
|
1,796.26
|
1,796.26
|
1,758.17
|
1,253.21
|
1,155.37
|
1,265.16
|
|
|
|
|
|
|
Total Assets
|
5,729.64
|
5,727.00
|
5,480.41
|
2,254.10
|
2,110.07
|
1,966.81
|
|
|
|
|
|
|
Total Debt*
|
--
|
169.67
|
258.36
|
38.58
|
69.16
|
95.57
|
|
|
|
|
|
|
Net Current Assets
|
1,150.33
|
1,150.33
|
1,052.76
|
1,135.81
|
852.28
|
917.64
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
53.31
|
57.92
|
18.11
|
6.07
|
6.07
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
368.32
|
673.35
|
384.77
|
457.20
|
330.00
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-254.57
|
-389.70
|
-362.35
|
-195.01
|
-136.14
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-165.15
|
-327.40
|
-39.99
|
-241.95
|
-156.48
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-51.40
|
-43.75
|
-17.57
|
20.24
|
37.38
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
3.32
|
4.68
|
19.14
|
11.79
|
16.16
|
17.83
|
|
|
|
|
|
|
Cash EPS (₹)
|
2.78
|
8.82
|
25.57
|
13.94
|
18.04
|
19.36
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
100.60
|
101.76
|
140.10
|
80.47
|
68.16
|
59.99
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
6.00
|
5.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
9.63
|
26.45
|
15.11
|
17.96
|
12.96
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
3.62
|
13.10
|
14.73
|
6.98
|
8.76
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
6.12
|
22.80
|
21.22
|
33.41
|
45.92
|
|
|
|
|
|
|
ROE (%)
|
3.29
|
4.02
|
17.25
|
15.87
|
25.21
|
33.52
|
|
|
|
|
|
|
ROA (%)
|
1.34
|
2.68
|
12.52
|
13.76
|
20.18
|
25.62
|
|
|
|
|
|
|
EBIT Margin (%)
|
5.81
|
10.56
|
24.16
|
33.41
|
39.26
|
41.10
|
|
|
|
|
|
|
Net Margin (%)
|
2.69
|
6.52
|
18.08
|
26.97
|
29.66
|
32.13
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
14.88
|
24.96
|
33.75
|
34.24
|
37.31
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-19.79
|
-13.03
|
148.11
|
-21.56
|
1.52
|
30.75
|
|
|
|
|
|
|
EBIT Growth (%)
|
-79.38
|
-61.97
|
79.45
|
-33.25
|
-3.03
|
31.91
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-73.52
|
-69.00
|
61.26
|
-26.99
|
-9.37
|
25.24
|
|
|
|
|
|
|
EPS Growth (%)
|
-84.10
|
-75.53
|
62.30
|
-27.00
|
-9.37
|
25.24
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
9.14
|
74.11
|
18.07
|
13.62
|
29.33
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
157.77
|
64.45
|
60.59
|
57.37
|
29.26
|
34.66
|
|
|
|
|
|
|
Price / Book Value
|
4.35
|
2.97
|
8.28
|
8.41
|
6.93
|
10.30
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
1.27
|
0.81
|
|
|
|
|
|
|
EV/EBITDA
|
48.43
|
25.29
|
34.27
|
36.80
|
19.39
|
23.41
|
|
|
|
|
|
|
Close Price (₹)
|
456.15
|
301.45
|
1,151.00
|
677.10
|
472.40
|
618.45
|
|
|
|
|
|
|
High Price (₹)
|
1,121.15
|
1,250.00
|
1,360.00
|
768.00
|
630.00
|
631.75
|
|
|
|
|
|
|
Low Price (₹)
|
266.70
|
266.70
|
597.00
|
375.00
|
387.50
|
425.70
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
16,759.68
|
11,550.78
|
29,528.48
|
17,226.26
|
12,033.34
|
15,730.84
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.04
|
0.07
|
0.02
|
0.04
|
0.06
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.02
|
0.02
|
0.02
|
0.04
|
0.04
|
|
|
|
|
|
|
Current Ratio
|
2.78
|
2.78
|
2.49
|
10.67
|
3.81
|
3.64
|
|
|
|
|
|
|
Quick Ratio
|
1.91
|
1.91
|
1.83
|
8.71
|
2.78
|
2.82
|
|
|
|
|
|
|
Interest Coverage
|
4.00
|
6.56
|
16.65
|
55.45
|
44.69
|
79.29
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.80
|
30.02
|
29.60
|
12.71
|
8.28
|
17.90
|
|
|
|
|
|
|
Asset Turnover
|
0.49
|
0.40
|
0.67
|
0.48
|
0.66
|
0.75
|
|
|
|
|
|
|
Receivable days
|
--
|
116.90
|
63.37
|
42.46
|
47.25
|
46.80
|
|
|
|
|
|
|
Inventory Days
|
--
|
82.83
|
48.87
|
94.43
|
81.11
|
66.93
|
|
|
|
|
|
|
Payable days
|
--
|
153.58
|
69.70
|
65.80
|
79.70
|
87.45
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
46.15
|
42.55
|
71.09
|
48.66
|
26.27
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
